Sharen Lee

Diabetes Research Unit, Cardiovascular Analytics Group, Hong Kong, China-UK Collaboration

China

SCHOLARLY PAPERS

4

DOWNLOADS

314

TOTAL CITATIONS

1

Scholarly Papers (4)

1.

Lower Risk of Gout in Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Versus Dipeptidyl Peptidase-4 (DPP4) Inhibitors in Type-2 Diabetes Patients: A Propensity Score-Matched Study with Competing Risk Analysis

Number of pages: 27 Posted: 24 Jan 2022
Kaili University - School of Educational Science, University of Oxford - Nuffield Department of Medicine, Diabetes Research Unit, Cardiovascular Analytics Group, Hong Kong, China-UK Collaboration, University of North Carolina (UNC) at Chapel Hill - Project-China, King’s College London, Diabetes Research Unit, Cardiovascular Analytics Group, Hong Kong, China-UK Collaboration, The Chinese University of Hong Kong (CUHK) - School of Life and Health Sciences, City University of Hong Kong (CityU) - School of Data Science, The University of Hong Kong - Department of Medicine, Tianjin Medical University - Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Second Hospital of Tianjin Medical University - Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease and The University of Hong Kong - Division of Clinical Pharmacology and Therapeutics
Downloads 115 (518,074)

Abstract:

Loading...

SGLT2i, DPP4i, Gout, diabetes, Rheumatology, renal function

2.

Lower Risk of Gout in Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Versus Dipeptidyl Peptidase-4 (DPP4) Inhibitors in Type-2 Diabetes Patients: A Propensity Score-Matched Study With Competing Risk Analysis

Number of pages: 29 Posted: 19 Jan 2022
Kaili University - School of Educational Science, University of Oxford - Nuffield Department of Medicine, Diabetes Research Unit, Cardiovascular Analytics Group, Hong Kong, China-UK Collaboration, University of North Carolina (UNC) at Chapel Hill - Project-China, King’s College London - Department of Biostatistics & Health Informatics, Diabetes Research Unit, Cardiovascular Analytics Group, Hong Kong, China-UK Collaboration, The Chinese University of Hong Kong (CUHK) - School of Life and Health Sciences, The University of Hong Kong, The University of Hong Kong - Department of Medicine, Tianjin Medical University - Department of General Surgery, Second Hospital of Tianjin Medical University - Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease and The University of Hong Kong - Division of Clinical Pharmacology and Therapeutics
Downloads 84 (640,668)

Abstract:

Loading...

3.

Effects of Warfarin on the Risks of Mortality, Acute Heart Failure, and Infection Resolution in Patients with Infective Endocarditis: A Target Trial Emulation

Number of pages: 28 Posted: 08 Mar 2024
The University of Hong Kong, University College London, The University of Hong Kong - Department of Emergency Medicine, The University of Hong Kong - University of Hong Kong, The University of Hong Kong - University of Hong Kong, Diabetes Research Unit, Cardiovascular Analytics Group, Hong Kong, China-UK Collaboration, City University of Hong Kong (CityU), Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Heart Failure Center, The University of Hong Kong - Division of Clinical Pharmacology and Therapeutics, The University of Hong Kong - Department of Emergency Medicine, University College London and Tianjin Medical University - The Second Hospital of Tianjin Medical University
Downloads 69 (715,810)
Citation 1

Abstract:

Loading...

infective endocarditis, anticoagulation, trial emulation, causal inference

4.

Comparisons of New-Onset Prostate Cancer in Type 2 Diabetes Mellitus Exposed to Sglt2i, Dpp4i and Glp1: A Population-Based Cohort Study

Number of pages: 34 Posted: 22 Mar 2024
The University of Hong Kong - Division of Clinical Pharmacology and Therapeutics, University of Oxford, Xi'an Jiaotong University (XJTU), The University of Hong Kong - University of Hong Kong, Cardiovascular Analytics Group, The University of Hong Kong - University of Hong Kong, affiliation not provided to SSRN, Memorial Sloan Kettering Cancer Center, University College London, The University of Hong Kong - University of Hong Kong, Diabetes Research Unit, Cardiovascular Analytics Group, Hong Kong, China-UK Collaboration, The University of Hong Kong - Division of Clinical Pharmacology and Therapeutics, Tianjin Medical University - The Second Hospital of Tianjin Medical University and University of Oxford - Nuffield Department of Medicine
Downloads 46 (874,040)

Abstract:

Loading...

Sodium-glucose cotransporter 2 inhibitors, Dipeptidyl peptidase-4 inhibitors, Glucagon-like peptide-1 receptor agonist, Prostate, prostate cancer